Opportunity
Federal Register #2026-19699
Proposed Pharmaceutical Production Activity at FTZ 57 for Eli Lilly and Company Drug Products
Posted
September 25, 2026
Respond By
November 04, 2026
Identifier
2026-19699
NAICS
325412, 325414, 325411
Eli Lilly and Company has notified the Department of Commerce, Foreign-Trade Zones Board of proposed production activity at FTZ 57 in Concord, North Carolina for a range of pharmaceutical products. - Government Buyer: - Department of Commerce, Foreign-Trade Zones Board - OEM/Vendor: - Eli Lilly and Company - Products/Services Requested: - Incretin-based therapies for blood glucose and weight management - CGRP monoclonal antibodies for migraine prevention - IL-17A and IL-13 monoclonal antibodies for chronic inflammatory conditions and atopic dermatitis - IL-23-targeted therapies for inflammatory bowel disease - Amylin receptor-targeted therapies for weight management - Amyloid-targeted therapies for early Alzheimer's disease - Dosage/packaged forms include filled syringes, vials, delivery pens, and semi-finished syringes - Medicine delivery devices and parts (e.g., Cap Cartridge Holder, Dry Side Subassembly, Damping Cup, RNS Puller, Base Cap) - Needles, glass vials, and syringes - Unique/Notable Requirements: - Use of foreign-status materials and components, some subject to duties under section 232 or 301 requiring privileged foreign status - No specific purchase quantities or part numbers provided - Public comment invited on proposed activity - OEM Highlight: - Eli Lilly and Company is the sole manufacturer mentioned - No services line items are specified - Period of performance is not specified
Description
Eli Lilly and Company has submitted a notification of proposed production activity at FTZ 57 in Concord, North Carolina, involving drug products. The proposed finished products include various drug therapies in dosage/packaged forms such as filled syringes, vials, or delivery pens. The notification details specific foreign-status materials and components used in production, some of which are subject to duties under trade laws. Public comments are invited until November 4, 2026.